PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-human CX3CR1, 25 tests
PE/Dazzle™ 594 anti-human EGFR, 100 tests
PE/Dazzle™ 594 anti-human FcεRIα, 100 tests
PE/Dazzle™ 594 anti-human FcεRIα, 25 tests
PE/Dazzle™ 594 anti-human FOXP3, 100 tests
PE/Dazzle™ 594 anti-human FOXP3, 25 tests
PE/Dazzle™ 594 anti-human HLA-A,B,C, 100 tests
PE/Dazzle™ 594 anti-human HLA-A,B,C, 25 tests
PE/Dazzle™ 594 anti-human HLA-DR, 100 tests
PE/Dazzle™ 594 anti-human HLA-DR, 25 tests
PE/Dazzle™ 594 anti-human Ig light chain λ, 100 tests
PE/Dazzle™ 594 anti-human Ig light chain λ, 25 tests
PE/Dazzle™ 594 anti-human IgD, 100 tests
PE/Dazzle™ 594 anti-human IgD, 25 tests
PE/Dazzle™ 594 anti-human IgM, 100 tests
PE/Dazzle™ 594 anti-human IgM, 25 tests